Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by IainCaimbeulon Jun 14, 2023 3:58pm
128 Views
Post# 35496698

RE:RE:RE:RE:WHAT REALLY IS GOING ON HERE.

RE:RE:RE:RE:WHAT REALLY IS GOING ON HERE.
LithLover wrote: It's been 2 years why hasn't there been a single contract or group signed?   Three reasons or a combination of:

1) The product doesn't work
2) It's too expensive and the value isn't there
3) Company doesn't know how to sell or market it

This is all on the CEO and board.  Reprice the test and get some marketing sales help.


As a longer term share holder at this time I would NOT buy an Aristotle test if where freely available on a retail level (which it is not), I just don't trust Stagezero anymore. The price has already been reduced by over 30% from $1499 to $949 USD without a single sale as far as I know. If Stagezero management were cattle I would not breed from that stock.

<< Previous
Bullboard Posts
Next >>